Cypherpunk Technologies (fka Leap Therapeutics) enters up to $200M ATM equity sales agreement with Cantor Fitzgerald

CYPHERPUNK TECHNOLOGIES INC.

Company entered into Controlled Equity Offering Sales Agreement with Cantor Fitzgerald & Co. to sell up to $200M of common stock.
Cantor will receive a commission of up to 3.0% of gross proceeds from each sale.
Sales will be made 'at the market' under existing shelf registration statement (File No. 333-278015).
Company has no obligation to sell any shares and can suspend or terminate agreement at any time.

item 1.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.